DIAGNOS signs new contract valued at $ 4.16 Million USD (5.26 Million CAD) with the Government of Mexico at ISSSTE to screen and monitor 320,000 diabetics in 2017 further to a successful…
…pilot program
DIAGNOS Announces Successful Pilot at Chaparral Medical Group in California and a 3 Year Contract with the Opening of a Second Eye Screening Clinic
BROSSARD, QUEBEC — (Marketwired) — 07/05/17 — Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces today the signing of a three year agreement with Chaparral Medical Group ("Chaparral"). We are also happy to announce the opening of a second eye screening clinic in California.—-The United States is a key market for Diagnos. By
DIAGNOS Receives Approval for Trading on the OTCQB Venture Market
BROSSARD, QUEBEC — (Marketwired) — 06/27/17 — DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, is pleased to announce that the Corporation–s common shares now trade on the OTCQB Venture Market, under the symbol "DGNOF." DIAGNOS continues to trade on the TSX Venture Exchange under its existing "ADK" symbol.Andre Larente, Pre
DIAGNOS Announces Amendment to its Stock Option Plan
BROSSARD, QUEBEC — (Marketwired) — 06/12/17 — DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces that the board of directors of the Corporation has approved an amendment to the Corporation–s Stock Option Plan ("Plan") in order to set the vesting from three (3) years to two (2) years, the first half (50%) number of options being exercisable
DIAGNOS Announces its New Mission in Healthcare after its Divestiture from the Mining Industry
BROSSARD, QUEBEC — (Marketwired) — 05/31/17 — Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces its new mission in healthcare.Further to the news release dated May 17th, 2017, the Corporation has received a certificate for 8,000,000 common shares of Majescor Resources Inc. pursuant to the sale of the assets from its mining division initially announc
DIAGNOS: Private Placement Closing Update
BROSSARD, QUEBEC — (Marketwired) — 04/28/17 — Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces an update to the April 27th, 2017 news release on the closing of the private placement with regards to the number of related parties, within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (&
DIAGNOS Announces closing of Private Placement
BROSSARD, QUEBEC — (Marketwired) — 04/27/17 — Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces that it has completed a private placement ("Private Placement"), initially announced on April 13, 2017, of 261 units (each a "Unit") for an aggregate value of $2,610,000 of which gross cash proceeds amount to $2,460,000 following the c
DIAGNOS Announces new partnership in Bangladesh with Eyes for All
BROSSARD, QUEBEC — (Marketwired) — 04/24/17 — Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare Artificial Intelligence services including screening, software and algorithm development, data analysis, image processing, announces today the signature of a new partnership agreement with Eyes for All (EFA), that will deploy the Diagnos solution in Bangladesh.This contract with Eyes for All in Bangladesh will focus on using the DIAGNOS A
DIAGNOS Announces Private Placement
BROSSARD, QUEBEC — (Marketwired) — 04/13/17 — Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces a private placement ("Private Placement") of up to 330 units (each a "Unit") for an aggregate value of up to $3,300,000.Each Unit consists of:At the sole option of the holder of the Debentures, the principal amount of the Debentures ma
DIAGNOS, in a strategic move, is divesting its Mining Division to focus on detection of critical health issues through the use of its Artificial Intelligence platform
BROSSARD, QUEBEC — (Marketwired) — 03/15/17 — Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in early detection of critical health issues through the use of Artificial Intelligence ("AI"), announces today the signing of an agreement, for total value of $800,000, for the sale of the assets from the mining division to Majescor Resources Inc ("Majescor") (TSX VENTURE: MJX).Under the terms of the agreement, on or before March 3